Similar articles for PMID: 19661370

Year	Number of Results
1983	1
1988	1
1991	2
1992	1
1996	1
1998	3
1999	7
2000	4
2001	6
2002	4
2003	9
2004	8
2005	10
2006	10
2007	10
2008	15
2009	8
2010	7
2011	6
2012	10
2013	4
2014	3
2015	2
2016	1
2017	2
2018	1
2019	2
2020	1
2021	2
2022	0

1

Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: a single institution phase II study.

Ralli M, Tourkantonis I, Makrilia N, Gkini E, Kotteas E, Gkiozos I, Katirtzoglou N, Syrigos K. Ralli M, et al. Anticancer Res. 2009 Aug;29(8):3441-4. Anticancer Res. 2009. PMID: 19661370 Free article. Clinical Trial.

2

Phase II study of gemcitabine plus docetaxel as second-line treatment in malignant pleural mesothelioma: a single institution study.

Tourkantonis I, Makrilia N, Ralli M, Alamara C, Nikolaidis I, Tsimpoukis S, Charpidou A, Kotanidou A, Syrigos K. Tourkantonis I, et al. Am J Clin Oncol. 2011 Feb;34(1):38-42. doi: 10.1097/COC.0b013e3181cae90e. Am J Clin Oncol. 2011. PMID: 20142722 Clinical Trial.

3

Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.

Zucali PA, Ceresoli GL, Garassino I, De Vincenzo F, Cavina R, Campagnoli E, Cappuzzo F, Salamina S, Soto Parra HJ, Santoro A. Zucali PA, et al. Cancer. 2008 Apr 1;112(7):1555-61. doi: 10.1002/cncr.23337. Cancer. 2008. PMID: 18286536 Free article. Clinical Trial.

4

Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.

van Haarst JM, Baas P, Manegold Ch, Schouwink JH, Burgers JA, de Bruin HG, Mooi WJ, van Klaveren RJ, de Jonge MJ, van Meerbeeck JP. van Haarst JM, et al. Br J Cancer. 2002 Feb 1;86(3):342-5. doi: 10.1038/sj.bjc.6600118. Br J Cancer. 2002. PMID: 11875695 Free PMC article. Clinical Trial.

5

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P. Vogelzang NJ, et al. J Clin Oncol. 2003 Jul 15;21(14):2636-44. doi: 10.1200/JCO.2003.11.136. J Clin Oncol. 2003. PMID: 12860938 Clinical Trial.

6

Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).

Pinto C, Marino A, De Pangher Manzini V, Benedetti G, Galetta D, Mazzanti P, Del Conte G, dell'Amore D, Piana E, Giaquinta S, Lopez M, Martoni A. Pinto C, et al. Lung Cancer. 2006 May;52(2):199-206. doi: 10.1016/j.lungcan.2006.01.002. Epub 2006 Mar 20. Lung Cancer. 2006. PMID: 16542747 Clinical Trial.

7

Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.

Jänne PA, Simon GR, Langer CJ, Taub RN, Dowlati A, Fidias P, Monberg M, Obasaju C, Kindler H. Jänne PA, et al. J Clin Oncol. 2008 Mar 20;26(9):1465-71. doi: 10.1200/JCO.2007.14.7611. J Clin Oncol. 2008. PMID: 18349397 Clinical Trial.

8

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study.

Favaretto AG, Aversa SM, Paccagnella A, Manzini Vde P, Palmisano V, Oniga F, Stefani M, Rea F, Bortolotti L, Loreggian L, Monfardini S. Favaretto AG, et al. Cancer. 2003 Jun 1;97(11):2791-7. doi: 10.1002/cncr.11405. Cancer. 2003. PMID: 12767092 Free article. Clinical Trial.

9

A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma.

Kovac V, Zwitter M, Rajer M, Marin A, Debeljak A, Smrdel U, Vrankar M. Kovac V, et al. Anticancer Drugs. 2012 Feb;23(2):230-8. doi: 10.1097/CAD.0b013e32834d7a1c. Anticancer Drugs. 2012. PMID: 22027538 Clinical Trial.

10

Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.

Simon GR, Verschraegen CF, Jänne PA, Langer CJ, Dowlati A, Gadgeel SM, Kelly K, Kalemkerian GP, Traynor AM, Peng G, Gill J, Obasaju CK, Kindler HL. Simon GR, et al. J Clin Oncol. 2008 Jul 20;26(21):3567-72. doi: 10.1200/JCO.2007.15.2868. J Clin Oncol. 2008. PMID: 18640937 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed